Dysregulated genomic and coding-transcriptomic factors in retinopathy of prematurity

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Gene Reports

• Publication date

  2022-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.genrep.2022.101558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.

  2021cited by this paper
• Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again

  2021cited by this paper
• Evaluation of expression level and methylation profile of CXX1 gene in breast cancer tissue blocks

  2021cited by this paper
• Cloning and expressing of interleukine 2 in amniotic membrane-derived mesenchymal stem cells, as a potent feeder layer

  2021cited by this paper
• Age dependency of the diabetes effects on the iris recognition systems performance evaluation results

  2020cited by this paper
• Oral vitamin A supplementation for ROP prevention in VLBW preterm infants

  2020cited by this paper
• Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity

  2020cited by this paper
• Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF–Resistant Diabetic Macular Edema

  2020cited by this paper
• CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.

  2020cited by this paper
• Updates on Novel Erythropoiesis-Stimulating Agents: Clinical and Molecular Approach

  2019cited by this paper
• Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.

  2019cited by this paper
• Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment

  2019cited by this paper
• Iris recognition under the influence of diabetes

  2019cited by this paper
• Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study

  2019cited by this paper
• Clinical Efficacy of Topical CoQ10 and Vitamin-E Eye-drop in Retinopathy of Prematurity

  2019cited by this paper
• EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS

  2019cited by this paper
• A Review on Leukemia and iPSC Technology: Application in Novel Treatment and Future.

  2018cited by this paper
• Comparative Effects of Coenzyme Q10 or n-3 Polyunsaturated Fatty Acid Supplementation on Retinal Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy

  2018cited by this paper
• The Efficacy of Omega-3 Supplement on Prevention of Retinopathy of Prematurity in Premature Infants: A Randomized Double-blinded Controlled trial.

  2018cited by this paper
• Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways

  2018cited by this paper
• Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity

  2018cited by this paper
• Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

  2017cited by this paper
• Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

  2017cited by this paper
• Retinopathy of Prematurity in Neonates and its Risk Factors: A Seven Year Study in Northern Iran

  2016cited by this paper
• Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia.

  2016cited by this paper
• INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY: Comparison Between Ranibizumab and Bevacizumab

  2015cited by this paper
• Cellular and molecular mechanisms of inflammation‐induced angiogenesis

  2015cited by this paper
• Broad targeting of angiogenesis for cancer prevention and therapy

  2015cited by this paper
• Determination of serum lipid profile in patients with diabetic macular edema that referred to Shahid Beheshti and Ayatollah Rouhani Hospitals, Babol during 2011-2012

  2015cited by this paper
• The Association Between Primary Open Angle Glaucoma and Clustered Components of Metabolic Syndrome

  2015cited by this paper
• Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.

  2015cited by this paper
• REACTIVATION OF RETINOPATHY OF PREMATURITY AFTER RANIBIZUMAB TREATMENT

  2015cited by this paper
• Genomics in the neonatal nursery: Focus on ROP.

  2015cited by this paper
• Clinical Presentation and Antibiotic Susceptibility of Contact Lens Associated Microbial Keratitis

  2015cited by this paper
• Prevalence of age-related macular degeneration among the elderly

  2015cited by this paper
• Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants.

  2014cited by this paper
• Serum concentrations of cytokines in infants with retinopathy of prematurity

  2014cited by this paper
• Clinical Presentation and Microbial Analyses of Contact Lens Keratitis; an Epidemiologic Study

  2014cited by this paper
• Regulation of fibroblast growth factor 2 expression in oxygen-induced retinopathy.

  2014cited by this paper
• Correlation between hyperglycemia and retinopathy of prematurity

  2014cited by this paper
• Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions

  2014cited by this paper
• Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.

  2014cited by this paper
• Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options.

  2013cited by this paper
• Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study

  2013cited by this paper
• Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

  2013cited by this paper
• Retinopathy of prematurity-incidence today.

  2013cited by this paper
• Early Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) Levels Can Prevent Risk of Retinopathy of Prematurity

  2013cited by this paper
• Pathological neoangiogenesis depends on oxidative stress regulation by ATM

  2012cited by this paper
• Perinatal infection, inflammation, and retinopathy of prematurity.

  2012cited by this paper
• Reduction of Retinopathy of Prematurity in Extremely Low Gestational Age Newborns Treated with Recombinant Human Cu/Zn Superoxide Dismutase

  2012cited by this paper
• An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.

  2012cited by this paper
• Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells

  2012cited by this paper
• Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphologic protective effect in oxygen-induced retinopathy.

  2011cited by this paper
• Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.

  2011cited by this paper
• Aberrant kinetics of bone marrow-derived endothelial progenitor cells in the murine oxygen-induced retinopathy model.

  2011cited by this paper
• Retinal ganglion cell death is induced by microglia derived pro‐inflammatory cytokines in the hypoxic neonatal retina

  2011cited by this paper
• Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

  2011cited by this paper
• Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants.

  2011cited by this paper
• Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity.

  2011cited by this paper
• Proliferative Retinopathy Is Associated with Impaired Increase in BDNF and RANTES Expression Levels after Preterm Birth

  2010cited by this paper
• Perinatal Systemic Inflammatory Response Syndrome and Retinopathy of Prematurity

  2010cited by this paper
• Short Communication: PPAR&ggr; Mediates a Direct Antiangiogenic Effect of &ohgr;3-PUFAs in Proliferative Retinopathy

  2010cited by this paper
• Serum levels of IGF1 are a useful predictor of retinopathy of prematurity

  2010cited by this paper
• Plasma sE-selectin in premature infants: a possible surrogate marker of retinopathy of prematurity.

  2010cited by this paper
• Non-erythroid effects of erythropoietin

  2010cited by this paper
• The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.

  2009cited by this paper
• TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.

  2009cited by this paper
• Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.

  2009cited by this paper
• Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.

  2009cited by this paper
• Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.

  2009cited by this paper
• A Pharmacokinetic and Dosing Study of Intravenous Insulin-Like Growth Factor-I and IGF-Binding Protein-3 Complex to Preterm Infants

  2009cited by this paper
• Lack of association of VEGF (−2578 C → A) and ANG 2 (−35 G → C) gene polymorphisms with the progression of retinopathy of prematurity

  2009cited by this paper
• Genetic Contributions to the Development of Retinopathy of Prematurity

  2009cited by this paper
• Effect of granulocyte colony-stimulating factor on the incidence of threshold retinopathy of prematurity.

  2009cited by this paper
• Deguelin inhibits retinal neovascularization by down-regulation of HIF-1α in oxygen-induced retinopathy

  2008cited by this paper
• VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity

  2008cited by this paper
• Erythropoietin deficiency decreases vascular stability in mice.

  2008cited by this paper
• The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity

  2008cited by this paper
• Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

  2007cited by this paper
• Lack of association of the VEGF gene promoter (−634 G→C and −460 C→T) polymorphism and the risk of advanced retinopathy of prematurity

  2007cited by this paper
• Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection.

  2007cited by this paper
• Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy

  2007cited by this paper
• Prävention von Retinopathien durch ω-3-Fettsäuren?

  2007cited by this paper
• Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications

  2007cited by this paper
• A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates

  2006cited by this paper
• Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.

  2006cited by this paper
• Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.

  2006cited by this paper
• Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity.

  2006cited by this paper
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy.

  2006cited by this paper
• Genetic Polymorphisms of Vascular Endothelial Growth Factor and Angiopoietin 2 in Retinopathy of Prematurity

  2006cited by this paper
• Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.

  2006cited by this paper
• Interleukin-10 High Producer Allele and Ultrasound-Defined Periventricular White Matter Abnormalities in Preterm Infants: A Preliminary Study

  2006cited by this paper
• High myopia associated with retinopathy of prematurity is primarily lenticular.

  2005cited by this paper
• Ectopic Norrin Induces Growth of Ocular Capillaries and Restores Normal Retinal Angiogenesis in Norrie Disease Mutant Mice

  2005cited by this paper
• Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore.

  2005cited by this paper
• Risk Factors of Retinopathy of Prematurity in Premature Infants Weighing Less Than 1600 g

  2005cited by this paper
• The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study

  2005cited by this paper
• Increased Expression of Chemokine KC, an Interleukin-8 Homologue, in a Model of Oxygen-Induced Retinopathy

  2005cited by this paper
• Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.

  2005cited by this paper

• No citing papers are available for this paper.